Adam D. Levy insider trades

Open-market stock purchases and sales by Adam D. Levy, Chief Financial Officer at Acrivon Therapeutics, Inc, from SEC Form 4 filings since Apr 1, 2025.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -19%.

Recent trades

DateStockTradeValue
May 18, 2026ACRV Acrivon Therapeutics, IncBought (not open market)—
Mar 1, 2026ACRV Acrivon Therapeutics, IncBought (not open market)—
Jan 14, 2026ACRV Acrivon Therapeutics, IncBought$15K

Companies traded

  • ACRV Acrivon Therapeutics, Inc: 1 buy, last May 18, 2026

Get free alerts when Adam D. Levy files a new trade →